Tyndall Capital Partners, L.P.

Latest statistics and disclosures from TYNDALL CAPITAL PARTNERS L P's latest quarterly 13F-HR filing:

  • TYNDALL CAPITAL PARTNERS L P was a net seller of stock by $0.

TYNDALL CAPITAL PARTNERS L P portfolio companies for March 2017 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Onconova Therapeutics 45.52 520832 3.04 0.00
Mma Capital Management 45.05 67399 23.25 0.00
Onconova Therapeutics Inc *w exp 07/07/202 9.43 390624 0.84 0.00